| Financial Year |
March 31 2023 |
| Monetary Funds |
1,966,419,762.83 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
687,297,362.75 |
| Accounts Receivable |
3,929,774,693.16 |
| Advances to Suppliers |
202,452,439.53 |
| Other Receivables |
209,426,421.09 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,041,143,529.03 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
164,888,510.58 |
| Total Current Assets |
8,648,376,575.37 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
97,923,968.97 |
| Investment Properties |
-- |
| Fixed Assetes |
1,542,573,866.21 |
| Under-construction Projects |
307,225,974.16 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
316,125,714.40 |
| R&D expenses |
-- |
| Goodwill |
150,967,558.11 |
| Long-Term Deferred and Prepaid Expenses |
20,659,600.07 |
| Deferred Income Tax Assets |
91,732,290.59 |
| Other Non-Current Assets |
63,414,992.10 |
| Sub-Total of Non-Current Assets |
2,727,914,248.16 |
| Total Assets |
11,376,290,823.53 |
| Short-Term Loans |
20,023,222.22 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,612,097,623.40 |
| Accounts Payable |
861,571,258.34 |
| Accounts Received In Advance |
22,935.78 |
| Employee Compensation Payable |
68,251,223.53 |
| Taxes Payable |
37,592,160.57 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
227,556,490.09 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
648,228,425.42 |
| Other Current Liabilities |
221,959,197.77 |
| Sub-Total of Current Liabilities |
4,809,847,924.21 |
| Long-term Loans |
878,327,601.70 |
| Bonds Payable |
408,312,185.07 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
54,629,413.42 |
| Other Non-Current Liabilities |
19,104,971.80 |
| Sub-Total of Non-Current Liabilities |
1,556,524,444.28 |
| Total Liabilities |
6,366,372,368.49 |
| Paid-In Capital(Or Share Stock) |
1,035,489,098.00 |
| Capital Surplus |
1,558,272,109.36 |
| Surplus Reserve |
360,729,914.21 |
| LESS:Treasury Stock |
199,833,572.98 |
| Undistributed Profits |
2,187,454,000.34 |
| Minority Stockholder's Interest |
19,796,073.45 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,990,122,381.59 |
| Owner's Equity（Stockholder's Equity） |
5,009,918,455.04 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,376,290,823.53 |
